Related Experiment Video
Updated: Aug 13, 2026

Derivation of Glial Restricted Precursors from E13 mice
Published on: June 20, 2012
GPR30 Functions as a Shared Inhibitory Signal for Both Pericyte-Mediated Angiogenesis and Oligodendrocyte Myelination
Si-Wen Hui1, Xing Gao1, Bin Yu2
1Brain and Intelligence Research Key Laboratory of Chongqing Education Commission, Department of Histology and Embryology, Third Military Medical University (Army Medical University), Chongqing, China.
Abstract:
Myelinogenesis is insufficient in numerous myelin-related diseases in the CNS, leading to functional impairments. Myelinogenesis couples with angiogenesis to ensure adequate need of oxygen and nutrients for oligodendrocyte (OL) differentiation. However, approaches to synchronize myelino-vascular coupling remain unavailable. We hypothesize the identification of shared signaling pathways in vascular cells and oligodendroglia may yield novel strategies to promote myelin repair through strengthening the blood vessel-myelination coupling. Here, single-cell sequencing and in situ hybridization revealed high expression of G-protein-coupled receptor 30 (Gpr30) in both vascular cells and oligodendroglia, with selective enrichment in pericytes and oligodendrocyte precursor cells (OPCs). Cell-specific deletion of GPR30 in pericytes driven by PDGFRβCreERT2 resulted in enhanced angiogenesis and myelination in developing brains. GPR30 deletion in OPCs or antagonizing GPR30 by G15 resulted in increased MBP-positive cell density and enhanced nanofiber wrapping capacity in vitro, thereby demonstrating an inhibiting role of GPR30 on OPC differentiation. To elucidate the coordinative role of GPR30 in both cell types, we employed NG2CreERT to induce a conditional knockout of GPR30 in both NG2-positive pericytes and OPCs. The conditional deletion of GPR30 enhanced myelination and increased vascular density in developing brains. Further, GPR30 cKO or G15 treatment enhanced myelin repair and functional recovery in the chronic neonatal hypoxia and lysolecithin-induced demyelination model, suggesting that antagonizing GPR30 is a promising strategy to synchronize angiogenesis with myelination to promote myelinogenesis. These findings establish GPR30 antagonism as a promising approach to enhance myelin repair through synchronizing pericyte-mediated angiogenesis and OPC differentiation.
Insights
Targeting G-protein-coupled receptor 30 (GPR30) enhances myelin repair by synchronizing blood vessel growth and oligodendrocyte precursor cell differentiation. Blocking GPR30 promotes myelin regeneration and functional recovery in demyelinating diseases.
Area of Science:
- Neuroscience
- Cell Biology
- Regenerative Medicine
Background:
- Myelin repair is crucial for treating central nervous system (CNS) diseases.
- Myelinogenesis and angiogenesis are coupled processes, but synchronization strategies are lacking.
- Shared signaling pathways between vascular cells and oligodendroglia may offer therapeutic targets.
Purpose of the Study:
- To investigate the role of G-protein-coupled receptor 30 (GPR30) in myelino-vascular coupling.
- To explore GPR30 antagonism as a strategy for promoting myelin repair.
- To identify shared signaling pathways for enhanced myelinogenesis.
Main Methods:
- Single-cell sequencing and in situ hybridization to identify GPR30 expression.
- Conditional knockout models (PDGFRβCreERT2, NG2CreERT) to study GPR30 function in pericytes and oligodendroglia.
- In vitro assays assessing oligodendrocyte precursor cell (OPC) differentiation.
- Demyelination models (neonatal hypoxia, lysolecithin) to evaluate therapeutic efficacy.
Main Results:
- GPR30 is highly expressed in pericytes and OPCs, regulating their function.
- GPR30 deletion in pericytes enhanced angiogenesis and myelination.
- GPR30 inhibition in OPCs promoted differentiation and myelin wrapping.
- GPR30 antagonism improved myelin repair and functional recovery in demyelination models.
Conclusions:
- GPR30 plays an inhibitory role in OPC differentiation and myelination.
- Synchronizing angiogenesis and myelination via GPR30 antagonism promotes myelin repair.
- Targeting GPR30 presents a promising therapeutic strategy for CNS demyelinating diseases.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Activation and Inactivation of G Proteins
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Glial Cells
GPCRs Regulate Adenylyl Cylase Activity
Two...
GPCR Desensitization

